Plasma pharmacokinetics and milk residues of flunixin and 5-hydroxy flunixin following different routes of administration in dairy cattle

Journal of Dairy Science

Volumn 95, Issue 12, 2012, Pages 7151-7157

  Kissell, L W ^a   Smith, G W ^a   Leavens, T L ^a   Baynes, R E ^a   Wu, H ^a   Riviere, J E ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Flunixin; Pharmacology; Residue

Indexed keywords

5 HYDROXYFLUNIXIN; 5-HYDROXYFLUNIXIN; CLONIXIN; DRUG DERIVATIVE; DRUG RESIDUE; FLUNIXIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CATTLE; CHEMISTRY; COMPARATIVE STUDY; FEMALE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MILK; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CATTLE; CLONIXIN; DRUG RESIDUES; FEMALE; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; MILK;

BOS;

EID: 84869488522     PISSN: 00220302     EISSN: 15253198     Source Type: Journal    
DOI: 10.3168/jds.2012-5754     Document Type: Article

References (33)

1. Abo-El-Sooud K., Al-Anati L. Pharmacokinetic study of flunixin and its interaction with enrofloxacin after intramuscular administration in calves. Vet. World 2011, 4:449-454.
2. Anderson K.L., Neff-Davis C.A., Bass V.D. Pharmacokinetics of flunixin meglumine in lactating cattle after single and multiple intramuscular and intravenous administrations. Am. J. Vet. Res. 1990, 51:1464-1467.
3. Benitz A.M. Pharmacology and pharmacokinetics of flunixin meglumine in the bovine 1984, 928-930.
4. Bonate P.L., Howard D.R. Pharmacokinetics in Drug Development: Clinical Study Design and Analysis 2004, Am. Assoc. Pharm. Sci., Arlington, VA.
5. Buur J.L., Baynes R.E., Smith G., Riviere J.E. Pharmacokinetics of flunixin meglumine in swine after intravenous dosing. J. Vet. Pharmacol. Ther. 2006, 29:437-440.
6. Fajt V.R., Wagner S.A., Norby B. Analgesic drug administration and attitudes about analgesia in cattle among bovine practitioners in the United States. J. Am. Vet. Med. Assoc. 2011, 238:755-767.
7. FDA (Food and Drug Administration). 1996. Animal Medicinal Drug Use Clarification Act of 1994 (AMDUCA). Title 21 Code of Federal Regulations, part 530. Fed. Regist. 7. FDA, Washington, DC.
8. FDA (Food and Drug Administration). 1998. Freedom of Information Summary: Supplemental new animal drug application (NADA 101-479). Accessed May 10, 2012. http://www.fda.gov/downloads/AnimalVeterinary/Products/ApprovedAnimalDrugProducts/FOIADrugSummaries/ucm064905.pdf.
9. FDA (Food and Drug Administration). 2004. Freedom of Information Summary: Supplemental new animal drug application (NADA 101-479). Accessed May 10, 2012. http://www.fda.gov/downloads/AnimalVeterinary/Products/ApprovedAnimalDrugProducts/FOIADrugSummaries/ucm064910.pdf.
10. FDA (Food and Drug Administration). 2010. Freedom of Information Summary: Original new animal drug application (NADA 141-312). Accessed May 10, 2012. http://www.fda.gov/downloads/AnimalVeterinary/Products/ApprovedAnimalDrugProducts/FOIADrugSummaries/UCM243040.pdf.
11. Gehring R., Baynes R.E., Riviere J.E. Application of risk assessment and management principles to the extralabel use of drugs in food-producing animals. J. Vet. Pharmacol. Ther. 2006, 29:5-14.
12. Gehring R., Smith G.W. An overview of factors affecting the disposition of intramammary preparations used to treat bovine mastitis. J. Vet. Pharmacol. Ther. 2006, 29:237-241.
13. Hardee G.E., Smith J.A., Harris S.J. Pharmacokinetics of flunixin meglumine in the cow. Res. Vet. Sci. 1985, 39:110-112.
14. Jaroszewski J., Jedziniak P., Markiewicz W., Grabowski T., Chrostowska M., Szprengier-Juszkiewicz T. Pharmacokinetics of flunixin in mature heifers following multiple intravenous administration. Pol. J. Vet. Sci. 2008, 11:199-203.
15. Königsson K., Törneke K., Engeland I.V., Odensvik K., Kindahl H. Pharmacokinetics and pharmacodynamic effects of flunixin after intravenous, intramuscular and oral administration to dairy goats. Acta Vet. Scand. 2003, 44:153-159.
16. Kopcha M., Kaneene J.B., Shea M.E., Miller R., Ahl A.S. Use of nonsteroidal anti-inflammatory drugs in food animal practice. J. Am. Vet. Med. Assoc. 1992, 201:1868-1872.
17. KuKanich B., Gehring R., Webb A.I., Craigmill A.L., Riviere J.E. Effect of formulation and route of administration on tissue residues and withdrawal times. J. Am. Vet. Med. Assoc. 2005, 227:1574-1577.
18. Lacroix M.Z., Gayrard V., Picard-Hagen N., Toutain P.L. Comparative bioavailability between two routes of administration of florfenicol and flunixin in cattle. Rev. Med. Vet. 2011, 162:321-324.
19. Lainesse C., Gehring R., Pasloske K., Smith G., Soback S., Wagner S., Whittem T. Challenges associated with the demonstration of bioequivalence of intramammary products in ruminants. J. Vet. Pharmacol. Ther. 2012, 35:65-79.
20. Landoni M.F., Cunningham F.M., Lees P. Determination of pharmacokinetics and pharmacodynamics of flunixin in calves by use of pharmacokinetic/pharmacodynamic modeling. Am. J. Vet. Res. 1995, 56:786-794.
21. Lichtenwalner D.M., Cameron B.D., Young C. The metabolism and pharmacokinetics of flunixin in cows and steers 1986, 1179-1183.
22. Mercer H.D., Geleta J.N., Schultz E.J., Wright W.W. Milk-out rates for antibiotics in intramammary infusion products used in the treatment of bovine mastitis: Relationship of somatic cell counts, milk production level, and drug vehicle. Am. J. Vet. Res. 1970, 31:1549-1560.
23. 2α metabolite concentrations after oral and intravenous administration in heifers. J. Vet. Pharmacol. Ther. 1995, 18:254-259.
24. Odensvik K., Johansson M.I. High-performance liquid chromatography method for determination of flunixin in bovine plasma and pharmacokinetics after single and repeated doses of the drug. Am. J. Vet. Res. 1995, 56:489-495.
25. Pyörälä S., Laurila T., Lehtonen S., Leppä S., Kaartinen L. Local tissue damage in cows after intramuscular administration of preparations containing phenylbutazone, flunixin, ketoprofen and metamizole. Acta Vet. Scand. 1999, 40:145-150.
26. Rantala M., Kaartinen L., Välimäki E., Stryrman M., Hiekkaranta M., Niemi A., Saari L., Pyörälä S. Efficacy and pharmacokinetics of enrofloxacin and flunixin meglumine for treatment of cows with experimentally induced Escherichia coli mastitis. J. Vet. Pharmacol. Ther. 2002, 25:251-258.
27. Smith G.W., Davis J.L., Tell L.A., Webb A.I., Riviere J.E. Extralabel use of nonsteroidal anti-inflammatory drugs in cattle. J. Am. Vet. Med. Assoc. 2008, 232:697-701.
28. Smith G.W., Gehring R., Riviere J.E., Yeatts J.L., Baynes R.E. Elimination kinetics for ceftiofur hydrochloride after intramammary administration in lactating dairy cows. J. Am. Vet. Med. Assoc. 2004, 224:1827-1830.
29. Stockler R.M., Morin D.E., Lantz R.K., Hurley W.L., Constable P.D. Effect of milk fraction on concentrations of cephapirin and desacetylcephapirin in bovine milk after intramammary infusion of cephapirin sodium. J. Vet. Pharmacol. Ther. 2009, 32:345-352.
30. Sundlof S.F., Kaneene J.B., Miller R.A. National survey on veterinarian-initiated drug use in lactating dairy cows. J. Am. Vet. Med. Assoc. 1995, 207:347-352.
31. USDA-FSIS (US Department of Agriculture Food Safety Inspection Service). 2005-2010. Red Book. Accessed May 10, 2012. http://www.fsis.usda.gov/Science/2005_Red_Book/index.asp.
32. Whittem T. Pharmacokinetics and milk discard times of pirlimycin after intramammary infusion: A population approach. J. Vet. Pharmacol. Ther. 1999, 22:41-51.
33. Wu H., Baynes R.E., Leavens T., Tell L.A., Riviere J.E. Use of population pharmacokinetic modeling and Monte Carlo simulation to capture individual animal variability in the prediction of flunixin withdrawal times in cattle. J. Vet. Pharmacol. Ther. 2012, http://dx.doi.org/10.1111/j.1365-2885.2012.01420.x.